Abstract
The c-erbB-2 gene is overexpressed in about 20% of human breast cancers. Four hundred and eighty-three cases previously examined by immunohistochemical staining for c-erbB-2 expression were analysed to assess the risk associated with the elevated protein expression. Oncoprotein expression was correlated with increasing tumour grade but not with oestrogen receptor status, nodal involvement, tumour size or age. There was an increased risk of relapse and death associated with c-erbB-2 expression irrespective of nodal involvement. This marker thus appears to be a significant prognostic factor in the early as well as the late stages of breast cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gullick, W., Love, S., Wright, C. et al. c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes. Br J Cancer 63, 434–438 (1991). https://doi.org/10.1038/bjc.1991.100
Issue Date:
DOI: https://doi.org/10.1038/bjc.1991.100
This article is cited by
-
HER2 expression on tumor-derived extracellular vesicles and circulating tumor cells in metastatic breast cancer
Breast Cancer Research (2020)
-
Risk factors associated with the incidence and time to onset of lapatinib-induced hepatotoxicity
Breast Cancer Research and Treatment (2019)
-
HER2/CEP17 ratio and HER2 immunohistochemistry predict clinical outcome after first-line trastuzumab plus taxane chemotherapy in patients with HER2 fluorescence in situ hybridization-positive metastatic breast cancer
Cancer Chemotherapy and Pharmacology (2013)
-
Clinical relevance of ErbB-2/HER2 nuclear expression in breast cancer
BMC Cancer (2012)
-
Study on predictive role of AR and EGFR family genes with response to neoadjuvant chemotherapy in locally advanced breast cancer in Indian women
Medical Oncology (2012)